SM
Somu Mohan
About Somu Mohan
Data last updated:
Somu Mohan has 3 years in corporate governance. Holds Additional Director and Director roles. Currently with 2 companies, including Alankar Benefit Fund Nidhi Limited and Swamy Well Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Alankar Benefit Fund Nidhi Limited at ₹3.75 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 07 Nov 2022 | 1994 | ₹3.75 Cr (FY 2024) | Active | |
| Director | 08 May 2023 | 2023 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Somu Mohan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Somu Mohan
Somu Mohan has 3 years in corporate governance. Holds Additional Director and Director roles. Currently with 2 companies, including Alankar Benefit Fund Nidhi Limited and Swamy Well Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Alankar Benefit Fund Nidhi Limited at ₹3.75 Cr (FY 2024).
Somu Mohan is associated with 2 companies as Additional Director and Director, including Alankar Benefit Fund Nidhi Limited (₹3.75 Cr), Swamy Well Pharma Private Limited.
Somu Mohan has expertise in General Business.
Somu Mohan has 3 years in corporate governance.
By reported revenue, the largest current company of Somu Mohan is Alankar Benefit Fund Nidhi Limited, with revenue of ₹3.75 Cr (FY 2024).
Somu Mohan currently holds positions at 2 companies: Alankar Benefit Fund Nidhi Limited (₹3.75 Cr), Swamy Well Pharma Private Limited.